78/100 B+ · Low risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

ELICHENS

Active 5599 7219 Active for 11 years

5599 · RC 808194138 · Active since 2014

B+

Overview

ELICHENS is a 5599 registered , France, since 2014. The company operates in the 7219 sector. Its TraceComp score of 78 (B+) indicates solid fundamentals and low apparent risk. With 11 years of operations, the company has an established track record in its market.

Company Information

Registration Number
808194138
Legal Form
5599
Registered
2014-11-23

Officers & Management

8 officers/directors on file — names, roles, appointment & resignation dates.

NameRoleStatus
MAKLOUF MARC ATTIA role 70 Current
+ 7 more in the full report

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Public Contracts Won

Awarded 1 public-sector contract totalling EUR 9,590 (DECP).

Which public buyers, contract titles, values and award dates.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

EU Funding

EU-funded innovation. Participated in 3 EU research projects, receiving €895,541 in EU contributions (CORDIS — Horizon Europe / Horizon 2020).

Source: CORDIS (EU Open Data, CC-BY). Cumulative EC contribution across the company’s projects.

Patent Portfolio

Active patent holder. 13 patents · 13 active · 13 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • No financial filings on record — score derives from registry signals and sector context

Data Sources & Freshness

Data sourced from: bulk register.